Stock listing
VRTX Stock Price, News, Filings & Events — Vertex Pharmaceuticals Incorporated
Selected listing: VRTX · BCBA · ARS · AR
This page tracks Vertex Pharmaceuticals Incorporated's VRTX:BCBA listing on BCBA in ARS for AR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRTX:BCBA. VRTX:BCBA is the stock-level entry point for investors researching Vertex Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vertex Pharmaceuticals Incorporated, trading under the ticker VRTX, is a leading biotechnology company based in the United States. With a market capitalization of approximately $121.16 billion, Vertex focuses on developing innovative therapies for serious diseases, particularly in the field of cystic fibrosis. The company is committed to advancing scientific research and improving patient outcomes through its...
- Ticker
- VRTX:BCBA
- Asset type
- Stock
- Market cap
- $137.30B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BCBA
- Currency
- ARS
Vertex Pharmaceuticals Incorporated VRTX:BCBA stock context
This page tracks Vertex Pharmaceuticals Incorporated's VRTX:BCBA listing on BCBA in ARS for AR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRTX:BCBA. VRTX:BCBA is the stock-level entry point for investors researching Vertex Pharmaceuticals Incorporated, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vertex Pharmaceuticals Incorporated, trading under the ticker VRTX, is a leading biotechnology company based in the United States. With a market capitalization of approximately $121.16 billion, Vertex focuses on developing innovative therapies for serious diseases, particularly in the field of cystic fibrosis. The company is committed to advancing scientific research and improving patient outcomes through its...
Latest news from Vertex Pharmaceuticals Incorporated
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
September 1, 2026
Vertex to Announce Second Quarter 2026 Financial Results on Monday, August 3, 2026
July 14, 2026
Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Or...
July 9, 2026
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
July 7, 2026
Vertex to Acquire Crinetics Pharmaceuticals
July 6, 2026
Vertex Pharmaceuticals Incorporated earnings calls
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2026 Earnings Call
August 3, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call
May 4, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2025 Earnings Call
February 12, 2026 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q2 2025 Earnings Call
August 4, 2025 · Replay with transcript and chapters
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2025 Earnings Call
May 5, 2025 · Replay with transcript and chapters
Research Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated investor report
Review AI stock analysis and investor report context for VRTX:BCBA.
Vertex Pharmaceuticals Incorporated company profile
View the public company page for Vertex Pharmaceuticals Incorporated on 6ix.
Vertex Pharmaceuticals Incorporated news
Read company news and market updates connected to Vertex Pharmaceuticals Incorporated.
Vertex Pharmaceuticals Incorporated investor events
Find investor webinars, events, and replay context for Vertex Pharmaceuticals Incorporated.
Alternate listings
VRTX:NASDAQ
US · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VX1:XETR
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VX1:GETTEX
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VX1:TRADEGATE
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
882807:LSX
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VRTX:BMV
MX · MXN
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VRTX34:BMFBOVESPA
BR · BRL
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
882807:LS
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
0QZU:LSE
GB · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VX1:FWB
DE · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
4VRTX:EUROTLX
IT · EUR
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.
VRTXD:BCBA
AR · USD
Alternate listing for Vertex Pharmaceuticals Incorporated; the primary context on this page is VRTX:BCBA.